Patrick Tang

Patrick Tang

License Number: 
P8054 Consultant (Laboratory Medicine / Microbiology)

Available in following clinical division(s): 

About Patrick Tang

Division Chief - Pathology Sciences

Patrick Tang (MD, PhD) is the Division Chief of Pathology Sciences at Sidra Medicine. In this role, Dr. Tang is responsible for the development and implementation of new molecular and genomics-based tests for microbiology and infectious diseases, and other diagnostic disciplines in the clinical laboratory at Sidra. Dr. Tang will also lead a research program to advance microbial genomics and metagenomics to combat infectious diseases and outbreaks as well as better understand the role of microorganisms in human health and disease.

Prior to joining Sidra, Dr. Tang was a Clinician-Scientist leader at the British Columbia Centre for Disease Control (BCCDC) and a Clinical Associate Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC). His various roles included leading both the Tuberculosis (TB)/Mycobacteriology Laboratory, which provides TB diagnostic and reference services for the province of British Columbia, and the Molecular Microbiology and Genomics Program, which is responsible for the development and implementation of new molecular assays and technology platforms at the BCCDC Public Health Microbiology and Reference Laboratory.

Dr. Tang completed a combined MD/PhD at UBC where his research focused on the molecular pathogenesis of Listeria monocytogenes. During his pathology residency training at the University of Toronto, he played a multifaceted role during the 2003 SARS outbreak from performing the first laboratory tests for an unknown virus to managing infected patients to integrating large clinical datasets in order to better understand the virus. His experiences during the SARS outbreak led him to a post-doctoral fellowship at the University of California, San Francisco, where he helped to develop metagenomics-based methods for virus discovery.

Dr. Tang’s clinical and research interests are in the application of genomics and metagenomics to infectious diseases and public health as well as the development of novel molecular diagnostics. He is a pioneer in the use of whole-genome sequencing to understand outbreaks and the use of metagenomics to uncover new infectious agents. His research projects have included searching for novel infectious agents in chronic diseases and outbreaks, using genomics to reduce TB transmission, studying the microbiomes of people and animals, tracking the spread of avian influenza, and looking for better ways to monitor water pollution.

  •   Degrees:  MD, PhD, FRCPC
  •   Specialities:  Medical Microbiology
Years of Experience
Clinical Excellence Awards


Depletion of Human DNA in Spiked Clinical Specimens for Improvement of Sensitivity of Pathogen Detection by Next-Generation Sequencing
J Clin Microbiol. 54(4):919-27...
Hasan MR, Rawat A, Tang P, Jithesh PV, Thomas E, Tan R, Tilley P
view abstract  →
Metagenomic investigation of plasma in individuals with ME/CFS highlights the importance of technical controls to elucidate contamination and batch effects
PLoS One 11(11): e0165691...
Miller RR, Uyaguari-Diaz M, McCabe MN, Montoya V, Gardy JL, Parker S, Steiner T, Hsiao W, Nesbitt MJ, Tang P, Patrick DM
view abstract  →
A comprehensive method for amplicon-based and metagenomic characterization of viruses, bacteria, and eukaryotes in freshwater samples
Microbiome. 2016, 4:20...
Uyaguari-Diaz MI, Chan M, Chaban BL, Croxen MA, Finke JF, Hill JE, Peabody MA, Van Rossum T, Suttle CA, Brinkman FSL, Isaac-Renton JL, Prystajecky NA, Tang P
view abstract  →
Declaring a tuberculosis outbreak over with genomic epidemiology
Microbial Genomics. 2016, 2...
Hatherell HA, Didelot X, Pollock SL, Tang P, Crisan A, Johnston JC, Colijn C, Gardy J
view abstract  →
A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics
Clin Microbiol Rev. 2015 Apr;28(2): 523-39...
Wlodarska M, Johnston JC, Gardy JL, Tang P
view abstract  →
Infection control in the new age of genomic epidemiology
Amer J Infect Control. 2016 (in press)...
Tang P, Croxen MA, Hasan MR, Hsiao WW, Hoang LM